本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

iTeos Therapeutics

10.15
0.0000
成交量:- -
成交额:1.12亿
市值:4.49亿
市盈率:-2.17
高:10.15
开:10.15
低:10.15
收:10.15
52周最高:17.63
52周最低:4.80
股本:4,420.54万
流通股本:3,323.73万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-4.6756
每股收益(LYR):-3.3210
净资产收益率:-34.97%
总资产收益率:-18.49%
市净率:0.91
市盈率(LYR):-3.06

数据加载中...

2025/08/29

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/08/29

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/08/29

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/08/29

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/08/29

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/08/29

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/08/29

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2025/08/29

重要事件披露

Form 8-K - Current report
2025/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/21

重要事件披露

Form 8-K - Current report
2025/06/17

重要事件披露

Form 8-K - Current report
2025/06/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/05

重要事件披露

Form 8-K - Current report
2025/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities